Rogaratinib (BAY1163877) in Chinese Patients
Clinical trial NCT03788603 · COMPLETED
Trial details
- NCT number
- NCT03788603
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2019-04-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.